HWY0201

HWY0201 is a local anesthetic combination candidate, likely composed of lidocaine and prilocaine, being developed by Kanion Pharmaceutical and Huawe Medicine. It is designed to provide localized pain relief during various gynecological and fertility-related procedures. The drug is currently in Phase 1 clinical development for indications including intrauterine device (IUD) placement and removal, uterine sounding, endometrial sampling, and hysteroscopic or colposcopic interventions. Additionally, it is being evaluated for use in reproductive medicine procedures such as hysterosalpingography, artificial insemination, and embryo transfer. HWY0201 functions by inhibiting voltage-gated sodium channels, thereby blocking the initiation and conduction of nerve impulses to achieve regional anesthesia.

Other names

Lidocaine and Prilocaine Cream